Revenue & Expenses
Period ending Sep 30, 2026 · select a line to chart its history
PHAR quarterly income statement | 117.56M |
| 133.16M |
| 15.36M |
| 102.19M |
| 72.31M |
| 29.57M |
| 45.03M |
| 29.89M |
| 8.82M |
| 22.43M |
| 22.43M |
| 25.40M |
| 22.43M |
| 0.32 |
| 0.362 |
| 0.30 |
| 31.24M |
| 35.39M |
| 707.78M |
PHAR quarterly balance sheet | 189.56M |
| 214.72M |
| 9.95M |
| 9.95M |
| 74.83M |
| 322.38M |
| 19.50M |
| 496.64M |
| 9.07M |
| 114.51M |
| 99.95M |
| 105.45M |
| 205.40M |
| -255.28M |
| 291.24M |
| 329.89M |
| 174.26M |
| 129.71M |
| 125.67M |
| 57.99M |
| 105.45M |
| 90.07M |
| 19.05M |
PHAR quarterly cash flow | 2.59M |
| -395.00K |
| 31.70M |
| -280.00K |
| 605.00K |
| -1.00M |
| -280.00K |
| 32.37M |
| 1.78M |